A malaria charity’s income increased by 20 per cent last year to a record high, latest documents show.
The Malaria Consortium’s accounts for the year ending 31 March 2023 show its income rose by £16.3m year on year to £100.7m.
The majority of these funds were restricted to use for seasonal malaria chemoprevention, which is the intermittent administration of a curative dose of antimalarial medicine to children.
Funding for SMC grew by £22.8m to £62.1m as the charity expanded its work into Mozambique, Nigeria and Uganda.
The largest grant received by the charity, totalling £34.2m, came from the Clear Fund, a UK government programme that delivers “global goals for sustainable development”, according to its website.
The charity also received a grant of £4.4m from the Bill and Melinda Gates Foundation.
The charity’s total expenditure increased by £14.9m to £94.3m last year, which is more than double the amount spent during the Covid-19 restrictions of 2020.
Marcel Tanner, chair of the Malaria Consortium, said: “As we reflect on the last 12 months, we are proud of the impact of the Malaria Consortium’s work and the positive change it continues to bring to communities across Africa and Asia.
“As a charity with global reach, our rich public health expertise was utilised to ensure the safe delivery of interventions – from large scale SMC campaigns across the Sahel to increasing health services for migrant workers along the Thailand-Cambodia border.
“We are excited by our exceptional growth and the continued belief and backing of our supporters and partners.”
The charity went through a change in leadership in November 2022 when James Tibenderana succeeded Charles Nelson as chief executive.
The charity’s average number of employees increased from 307 to 332 in 2022/23 with the highest earner making between £120,000 and £130,000, the accounts show.